<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-08-01" modified="2020-10-07" version="191">
<accession>P16662</accession>
<accession>B2R810</accession>
<accession>Q6GTW0</accession>
<name>UD2B7_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="18">UDP-glucuronosyltransferase 2B7</fullName>
<shortName>UDPGT 2B7</shortName>
<shortName>UGT2B7</shortName>
<ecNumber evidence="8 10 11 12 15 16 17">2.4.1.17</ecNumber>
</recommendedName>
<alternativeName>
<fullName>3,4-catechol estrogen-specific UDPGT</fullName>
</alternativeName>
<alternativeName>
<fullName>UDP-glucuronosyltransferase 2B9</fullName>
<shortName>UDPGT 2B9</shortName>
</alternativeName>
<alternativeName>
<fullName>UDPGTh-2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="31">UGT2B7</name>
<name type="synonym">UGTB2B9</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="7900" last="7906">
<title>Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates.</title>
<authorList>
<person name="Ritter J.K."/>
<person name="Sheen Y.Y."/>
<person name="Owens I.S."/>
</authorList>
<dbReference type="PubMed" id="2159463"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT HIS-268</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-68</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="6908" last="6914">
<title>4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7.</title>
<authorList>
<person name="Samokyszyn V.M."/>
<person name="Gall W.E."/>
<person name="Zawada G."/>
<person name="Freyaldenhoven M.A."/>
<person name="Chen G."/>
<person name="Mackenzie P.I."/>
<person name="Tephly T.R."/>
<person name="Radominska-Pandya A."/>
</authorList>
<dbReference type="PubMed" id="10702251"/>
<dbReference type="DOI" id="10.1074/jbc.275.10.6908"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="5222" last="5232">
<title>Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.</title>
<authorList>
<person name="Lepine J."/>
<person name="Bernard O."/>
<person name="Plante M."/>
<person name="Tetu B."/>
<person name="Pelletier G."/>
<person name="Labrie F."/>
<person name="Belanger A."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="15472229"/>
<dbReference type="DOI" id="10.1210/jc.2004-0331"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Drug Metab. Dispos." volume="33" first="139" last="146">
<title>Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.</title>
<authorList>
<person name="Picard N."/>
<person name="Ratanasavanh D."/>
<person name="Premaud A."/>
<person name="Le Meur Y."/>
<person name="Marquet P."/>
</authorList>
<dbReference type="PubMed" id="15470161"/>
<dbReference type="DOI" id="10.1124/dmd.104.001651"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Biochem. Pharmacol." volume="76" first="763" last="772">
<title>The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan.</title>
<authorList>
<person name="Alonen A."/>
<person name="Finel M."/>
<person name="Kostiainen R."/>
</authorList>
<dbReference type="PubMed" id="18674515"/>
<dbReference type="DOI" id="10.1016/j.bcp.2008.07.006"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Biochem. Pharmacol." volume="75" first="1240" last="1250">
<title>Identification of human UDP-glucuronosyltransferases catalyzing hepatic 1alpha,25-dihydroxyvitamin D3 conjugation.</title>
<authorList>
<person name="Hashizume T."/>
<person name="Xu Y."/>
<person name="Mohutsky M.A."/>
<person name="Alberts J."/>
<person name="Hadden C."/>
<person name="Kalhorn T.F."/>
<person name="Isoherranen N."/>
<person name="Shuhart M.C."/>
<person name="Thummel K.E."/>
</authorList>
<dbReference type="PubMed" id="18177842"/>
<dbReference type="DOI" id="10.1016/j.bcp.2007.11.008"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Drug Metab. Dispos." volume="36" first="2307" last="2315">
<title>The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.</title>
<authorList>
<person name="Itaeaho K."/>
<person name="Mackenzie P.I."/>
<person name="Ikushiro S."/>
<person name="Miners J.O."/>
<person name="Finel M."/>
</authorList>
<dbReference type="PubMed" id="18719240"/>
<dbReference type="DOI" id="10.1124/dmd.108.022731"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Drug Metab. Dispos." volume="37" first="417" last="423">
<title>UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly.</title>
<authorList>
<person name="Sten T."/>
<person name="Bichlmaier I."/>
<person name="Kuuranne T."/>
<person name="Leinonen A."/>
<person name="Yli-Kauhaluoma J."/>
<person name="Finel M."/>
</authorList>
<dbReference type="PubMed" id="19022937"/>
<dbReference type="DOI" id="10.1124/dmd.108.024844"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2013" name="Drug Metab. Dispos." volume="41" first="582" last="591">
<title>Regiospecificity and stereospecificity of human UDP-glucuronosyltransferases in the glucuronidation of estriol, 16-epiestriol, 17-epiestriol, and 13-epiestradiol.</title>
<authorList>
<person name="Sneitz N."/>
<person name="Vahermo M."/>
<person name="Mosorin J."/>
<person name="Laakkonen L."/>
<person name="Poirier D."/>
<person name="Finel M."/>
</authorList>
<dbReference type="PubMed" id="23288867"/>
<dbReference type="DOI" id="10.1124/dmd.112.049072"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="Drug Metab. Dispos." volume="41" first="1616" last="1620">
<title>The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidation.</title>
<authorList>
<person name="Perreault M."/>
<person name="Gauthier-Landry L."/>
<person name="Trottier J."/>
<person name="Verreault M."/>
<person name="Caron P."/>
<person name="Finel M."/>
<person name="Barbier O."/>
</authorList>
<dbReference type="PubMed" id="23756265"/>
<dbReference type="DOI" id="10.1124/dmd.113.052613"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2015" name="J. Steroid Biochem. Mol. Biol." volume="154" first="104" last="111">
<title>Glucuronidation of estrone and 16alpha-hydroxyestrone by human UGT enzymes: The key roles of UGT1A10 and UGT2B7.</title>
<authorList>
<person name="Kallionpaeae R.A."/>
<person name="Jaervinen E."/>
<person name="Finel M."/>
</authorList>
<dbReference type="PubMed" id="26220143"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2015.07.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="369" first="498" last="511">
<title>Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.</title>
<authorList>
<person name="Miley M.J."/>
<person name="Zielinska A.K."/>
<person name="Keenan J.E."/>
<person name="Bratton S.M."/>
<person name="Radominska-Pandya A."/>
<person name="Redinbo M.R."/>
</authorList>
<dbReference type="PubMed" id="17442341"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.03.066"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 285-451</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION TOWARDS STEROIDS</scope>
<scope>MUTAGENESIS OF SER-15; HIS-35; ASP-151; THR-373; HIS-374; ASN-378; GLY-379; ASP-398 AND GLN-399</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Pharmacogenetics" volume="10" first="679" last="685">
<title>Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.</title>
<authorList>
<person name="Bhasker C.R."/>
<person name="McKinnon W."/>
<person name="Stone A."/>
<person name="Lo A.C."/>
<person name="Kubota T."/>
<person name="Ishizaki T."/>
<person name="Miners J.O."/>
</authorList>
<dbReference type="PubMed" id="11186130"/>
<dbReference type="DOI" id="10.1097/00008571-200011000-00002"/>
</citation>
<scope>VARIANT HIS-268</scope>
</reference>
<comment type="function">
<text evidence="4 6 7 8 10 11 12 14 15 16 17">UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:10702251, PubMed:15472229, PubMed:15470161, PubMed:18674515, PubMed:18719240, PubMed:19022937, PubMed:23288867, PubMed:23756265, PubMed:26220143, PubMed:17442341). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:15470161, PubMed:18674515, PubMed:23756265). Catalyzes the glucuronidation of endogenous steroid hormones such as androgens (epitestosterone, androsterone) and estrogens (estradiol, epiestradiol, estriol, catechol estrogens) (PubMed:2159463, PubMed:15472229, PubMed:18719240, PubMed:19022937, PubMed:23288867, PubMed:26220143, PubMed:17442341). Also regulates the levels of retinoic acid, a major metabolite of vitamin A involved in apoptosis, cellular growth and differentiation, and embryonic development (PubMed:10702251). Contributes to bile acid (BA) detoxification by catalyzing the glucuronidation of BA substrates, which are natural detergents for dietary lipids absorption (PubMed:23756265). Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist losartan, caderastan and zolarsatan, drugs which can inhibit the effect of angiotensin II (PubMed:18674515). Also metabolizes mycophenolate, an immunosuppressive agent (PubMed:15470161).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4 6 7 8 10 11 12 15 16 17">
<text>glucuronate acceptor + UDP-alpha-D-glucuronate = acceptor beta-D-glucuronoside + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:21032"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:132367"/>
<dbReference type="ChEBI" id="CHEBI:132368"/>
<dbReference type="EC" id="2.4.1.17"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="20 21 22 23 25 26 27 28 29 30">
<dbReference type="Rhea" id="RHEA:21033"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="11 15">
<text>17alpha-estradiol + UDP-alpha-D-glucuronate = 17alpha-estradiol 17-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52872"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17160"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:136642"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="26 28">
<dbReference type="Rhea" id="RHEA:52873"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="11">
<text>17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-estradiol 17-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52464"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:16469"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:82961"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="26">
<dbReference type="Rhea" id="RHEA:52465"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>2-hydroxy-17beta-estradiol + UDP-alpha-D-glucuronate = 2-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:53004"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:28744"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:136931"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="22">
<dbReference type="Rhea" id="RHEA:53005"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>4-hydroxy-17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-estradiol 4-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:53040"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:62845"/>
<dbReference type="ChEBI" id="CHEBI:136937"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="22">
<dbReference type="Rhea" id="RHEA:53041"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>4-hydroxyestrone + UDP-alpha-D-glucuronate = estrone 4-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:53060"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:87602"/>
<dbReference type="ChEBI" id="CHEBI:136970"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="22">
<dbReference type="Rhea" id="RHEA:53061"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="17">
<text>16alpha-hydroxyestrone + UDP-alpha-D-glucuronate = 16alpha-hydroxyestrone 16-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52452"/>
<dbReference type="ChEBI" id="CHEBI:776"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:136636"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="30">
<dbReference type="Rhea" id="RHEA:52453"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>16alpha,17beta-estriol + UDP-alpha-D-glucuronate = 16alpha,17beta-estriol 16-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52472"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:27974"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:136650"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="28">
<dbReference type="Rhea" id="RHEA:52473"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>16beta,17beta-estriol + UDP-alpha-D-glucuronate = 16beta,17beta-estriol 16-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52880"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:87620"/>
<dbReference type="ChEBI" id="CHEBI:136886"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="28">
<dbReference type="Rhea" id="RHEA:52881"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>16alpha,17alpha-estriol + UDP-alpha-D-glucuronate = 16alpha,17alpha-estriol 16-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52920"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:42156"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:136884"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="28">
<dbReference type="Rhea" id="RHEA:52921"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>16alpha,17alpha-estriol + UDP-alpha-D-glucuronate = 16alpha,17alpha-estriol 17-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52916"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:42156"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:136883"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="28">
<dbReference type="Rhea" id="RHEA:52917"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12">
<text>epitestosterone + UDP-alpha-D-glucuronate = epitestosterone 17-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52568"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:42534"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:136673"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="27">
<dbReference type="Rhea" id="RHEA:52569"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="16">
<text>hyodeoxycholate + UDP-alpha-D-glucuronate = H(+) + hyodeoxycholate 6-O-(beta-D-glucuronate) + UDP</text>
<dbReference type="Rhea" id="RHEA:52964"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:58875"/>
<dbReference type="ChEBI" id="CHEBI:136905"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="29">
<dbReference type="Rhea" id="RHEA:52965"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="16">
<text>hyocholate + UDP-alpha-D-glucuronate = H(+) + hyocholate 6-O-(beta-D-glucuronate) + UDP</text>
<dbReference type="Rhea" id="RHEA:52968"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:133661"/>
<dbReference type="ChEBI" id="CHEBI:136906"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="29">
<dbReference type="Rhea" id="RHEA:52969"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>all-trans-retinoate + UDP-alpha-D-glucuronate = all-trans-retinoyl-1-O-(beta-D-glucuronate) + UDP</text>
<dbReference type="Rhea" id="RHEA:55768"/>
<dbReference type="ChEBI" id="CHEBI:35291"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:139181"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="20">
<dbReference type="Rhea" id="RHEA:55769"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="4">
<text>all-trans-4-hydroxyretinoate + UDP-alpha-D-glucuronate = 4-hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinoate + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:55776"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:134178"/>
<dbReference type="ChEBI" id="CHEBI:139182"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="20">
<dbReference type="Rhea" id="RHEA:55777"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="6">
<text>mycophenolate + UDP-alpha-D-glucuronate = mycophenolic acid O-acyl-beta-D-glucuronide + UDP</text>
<dbReference type="Rhea" id="RHEA:63700"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:62932"/>
<dbReference type="ChEBI" id="CHEBI:66982"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="21">
<dbReference type="Rhea" id="RHEA:63701"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="10">
<text>losartan + UDP-alpha-D-glucuronate = losartan-2-N-beta-D-glucuronide + UDP</text>
<dbReference type="Rhea" id="RHEA:63720"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:149504"/>
<dbReference type="ChEBI" id="CHEBI:149507"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="25">
<dbReference type="Rhea" id="RHEA:63721"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="10">
<text>candesartan + UDP-alpha-D-glucuronate = candesartan O-beta-D-glucuronoside + UDP</text>
<dbReference type="Rhea" id="RHEA:63724"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:149509"/>
<dbReference type="ChEBI" id="CHEBI:149522"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="25">
<dbReference type="Rhea" id="RHEA:63725"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="10">
<text>candesartan + UDP-alpha-D-glucuronate = candesartan-2-N-beta-D-glucuronide + UDP</text>
<dbReference type="Rhea" id="RHEA:63728"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:149509"/>
<dbReference type="ChEBI" id="CHEBI:149523"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="25">
<dbReference type="Rhea" id="RHEA:63729"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="10">
<text>UDP-alpha-D-glucuronate + zolasartan = UDP + zolarsartan O-beta-D-glucuronoside</text>
<dbReference type="Rhea" id="RHEA:63732"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:149524"/>
<dbReference type="ChEBI" id="CHEBI:149526"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="25">
<dbReference type="Rhea" id="RHEA:63733"/>
</physiologicalReaction>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="7">10 uM for 17beta-estradiol/estradiol (when assaying glucuronidation at position 17)</KM>
<KM evidence="7">33 uM for the formation of 2-hydroxy-17beta-estradiol (when assaying glucuronidation at position 2)</KM>
<KM evidence="7">33 uM for 2-hydroxy-17beta-estradiol (when assaying glucuronidation at position 3)</KM>
<KM evidence="7">22 uM for 4-hydroxy-17beta-estradiol (when assaying glucuronidation at position 3)</KM>
<KM evidence="7">10 uM for 4-hydroxy-17beta-estradiol (when assaying glucuronidation at position 4)</KM>
<KM evidence="7">62 uM for 4-hydroxy-estrone (when assaying glucuronidation at position 4)</KM>
<KM evidence="17">3.4 uM for 16alpha-hydroxyestrone (when assaying glucuronidation at position 16)</KM>
<KM evidence="11">5.96 uM for 17beta-estradiol/estradiol (when assaying glucuronidation at position 17)</KM>
<KM evidence="12">1.7 uM for epitestosterone (when assaying glucuronidation at position 17)</KM>
<KM evidence="4">1.3 uM for all-trans-retinoate</KM>
<KM evidence="4">221 uM for all-trans-4-hydroxyretinoate</KM>
<KM evidence="6">200 uM for mycophenolate (when assaying glucuronidation at position 6')</KM>
<KM evidence="10">162.3 uM for losartan</KM>
<KM evidence="9">4.2 uM for calcitriol (when assaying glucuronidation at position 25)</KM>
<Vmax evidence="7">42 pmol/min/mg enzyme for the formation of 17beta-estradiol 17-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="7">14 pmol/min/mg enzyme for the formation of 2-hydroxy-17beta-estradiol 2-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="7">372 pmol/min/mg enzyme for the formation of 2-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="7">48 pmol/min/mg enzyme for the formation of 4-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="7">523 pmol/min/mg enzyme for the formation of 4-hydroxy-17beta-estradiol 4-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="7">872 pmol/min/mg enzyme for the formation of 4-hydroxy-estrone 4-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="17">190 pmol/min/mg enzyme for the formation of 16alpha-hydroxyestrone 16-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="11">590 pmol/min/mg enzyme for the formation of 17alpha-estradiol 17-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="11">631 pmol/min/mg enzyme for the formation of 17beta-estradiol 17-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="15">32.6 pmol/min/mg enzyme for the formation of 17alpha-estradiol 17-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="15">4.5 pmol/min/mg enzyme for the formation of 17beta-estradiol 17-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="15">1198 pmol/min/mg enzyme for the formation of 16alpha,17beta-estriol 16-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="15">2717 pmol/min/mg enzyme for the formation of 16beta,17beta-estriol 16-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="15">35.2 pmol/min/mg enzyme for the formation of 16alpha,17alpha-estriol 16-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="15">1537 pmol/min/mg enzyme for the formation of 16alpha,17alpha-estriol 17-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="12">337 pmol/min/mg enzyme for the formation of epitestosterone 17-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="4">523 pmol/min/mg enzyme for the formation of all-trans-retinoate 1-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="4">1709 pmol/min/mg enzyme for the formation of 4-hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinoate</Vmax>
<Vmax evidence="7">220 pmol/min/mg enzyme for the formation of mycophenolic acid O-acyl-glucuronide</Vmax>
<Vmax evidence="10">16.1 pmol/min/mg enzyme for the formation of losartan-N2-beta-D-glucuronide</Vmax>
<Vmax evidence="9">1.4 pmol/min/mg enzyme for the formation of calcitriol 25-O-(beta-D-glucuronate)</Vmax>
<text evidence="21 24">Some kinetic parameters were assessed using commercial enzymes, which may represent a mix of both active and inactive protein forms, and therefore modify the kinetic values.</text>
</kinetics>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4">Endoplasmic reticulum membrane</location>
<topology evidence="3">Single-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="polymorphism">
<text evidence="5 14">2 alleles have been identified: UGT2B7*1 (His-268) and UGT2B7*2 (Tyr-268). The sequence shown is that of allele UGT2B7*2.</text>
</comment>
<comment type="similarity">
<text evidence="19">Belongs to the UDP-glycosyltransferase family.</text>
</comment>
<dbReference type="EC" id="2.4.1.17" evidence="8 10 11 12 15 16 17"/>
<dbReference type="EMBL" id="J05428">
<property type="protein sequence ID" value="AAA36793.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313190">
<property type="protein sequence ID" value="BAG36007.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223142">
<property type="protein sequence ID" value="BAD96862.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC111000">
<property type="protein sequence ID" value="AAY41045.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC030974">
<property type="protein sequence ID" value="AAH30974.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3526.1"/>
<dbReference type="PIR" id="A35366">
<property type="entry name" value="A35366"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001065.2">
<property type="nucleotide sequence ID" value="NM_001074.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001317648.1">
<property type="nucleotide sequence ID" value="NM_001330719.1"/>
</dbReference>
<dbReference type="PDB" id="2O6L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=285-451"/>
</dbReference>
<dbReference type="PDBsum" id="2O6L"/>
<dbReference type="SMR" id="P16662"/>
<dbReference type="BioGRID" id="113211">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="P16662">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000304811"/>
<dbReference type="ChEMBL" id="CHEMBL4370"/>
<dbReference type="DrugBank" id="DB13783">
<property type="generic name" value="Acemetacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB06403">
<property type="generic name" value="Ambrisentan"/>
</dbReference>
<dbReference type="DrugBank" id="DB01217">
<property type="generic name" value="Anastrozole"/>
</dbReference>
<dbReference type="DrugBank" id="DB11638">
<property type="generic name" value="Artenimol"/>
</dbReference>
<dbReference type="DrugBank" id="DB11936">
<property type="generic name" value="Bempedoic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00564">
<property type="generic name" value="Carbamazepine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01136">
<property type="generic name" value="Carvedilol"/>
</dbReference>
<dbReference type="DrugBank" id="DB06119">
<property type="generic name" value="Cenobamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06777">
<property type="generic name" value="Chenodeoxycholic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00318">
<property type="generic name" value="Codeine"/>
</dbReference>
<dbReference type="DrugBank" id="DB14635">
<property type="generic name" value="Curcumin sulfate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06695">
<property type="generic name" value="Dabigatran etexilate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06292">
<property type="generic name" value="Dapagliflozin"/>
</dbReference>
<dbReference type="DrugBank" id="DB09213">
<property type="generic name" value="Dexibuprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00586">
<property type="generic name" value="Diclofenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB05928">
<property type="generic name" value="Dovitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB13874">
<property type="generic name" value="Enasidenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00445">
<property type="generic name" value="Epirubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB11827">
<property type="generic name" value="Ertugliflozin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00783">
<property type="generic name" value="Estradiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00977">
<property type="generic name" value="Ethinylestradiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00749">
<property type="generic name" value="Etodolac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00973">
<property type="generic name" value="Ezetimibe"/>
</dbReference>
<dbReference type="DrugBank" id="DB01544">
<property type="generic name" value="Flunitrazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00712">
<property type="generic name" value="Flurbiprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01095">
<property type="generic name" value="Fluvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00983">
<property type="generic name" value="Formoterol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01241">
<property type="generic name" value="Gemfibrozil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00327">
<property type="generic name" value="Hydromorphone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01050">
<property type="generic name" value="Ibuprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00328">
<property type="generic name" value="Indomethacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00465">
<property type="generic name" value="Ketorolac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00598">
<property type="generic name" value="Labetalol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00555">
<property type="generic name" value="Lamotrigine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01006">
<property type="generic name" value="Letrozole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00678">
<property type="generic name" value="Losartan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00227">
<property type="generic name" value="Lovastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB09212">
<property type="generic name" value="Loxoprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01252">
<property type="generic name" value="Mitiglinide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00295">
<property type="generic name" value="Morphine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00688">
<property type="generic name" value="Mycophenolate mofetil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01024">
<property type="generic name" value="Mycophenolic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB06230">
<property type="generic name" value="Nalmefene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00788">
<property type="generic name" value="Naproxen"/>
</dbReference>
<dbReference type="DrugBank" id="DB11837">
<property type="generic name" value="Osilodrostat"/>
</dbReference>
<dbReference type="DrugBank" id="DB00842">
<property type="generic name" value="Oxazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01174">
<property type="generic name" value="Phenobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB08860">
<property type="generic name" value="Pitavastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00794">
<property type="generic name" value="Primidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00503">
<property type="generic name" value="Ritonavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB06207">
<property type="generic name" value="Silodosin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00641">
<property type="generic name" value="Simvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00870">
<property type="generic name" value="Suprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00675">
<property type="generic name" value="Tamoxifen"/>
</dbReference>
<dbReference type="DrugBank" id="DB06204">
<property type="generic name" value="Tapentadol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00197">
<property type="generic name" value="Troglitazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB13609">
<property type="generic name" value="Umifenovir"/>
</dbReference>
<dbReference type="DrugBank" id="DB06235">
<property type="generic name" value="Vadimezan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00313">
<property type="generic name" value="Valproic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB06737">
<property type="generic name" value="Zaltoprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00495">
<property type="generic name" value="Zidovudine"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000001695"/>
<dbReference type="CAZy" id="GT1">
<property type="family name" value="Glycosyltransferase Family 1"/>
</dbReference>
<dbReference type="GlyGen" id="P16662">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P16662"/>
<dbReference type="PhosphoSitePlus" id="P16662"/>
<dbReference type="BioMuta" id="UGT2B7"/>
<dbReference type="DMDM" id="136727"/>
<dbReference type="jPOST" id="P16662"/>
<dbReference type="MassIVE" id="P16662"/>
<dbReference type="PaxDb" id="P16662"/>
<dbReference type="PeptideAtlas" id="P16662"/>
<dbReference type="PRIDE" id="P16662"/>
<dbReference type="ProteomicsDB" id="53391"/>
<dbReference type="Antibodypedia" id="44203">
<property type="antibodies" value="170 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7364"/>
<dbReference type="Ensembl" id="ENST00000305231">
<property type="protein sequence ID" value="ENSP00000304811"/>
<property type="gene ID" value="ENSG00000171234"/>
</dbReference>
<dbReference type="GeneID" id="7364"/>
<dbReference type="KEGG" id="hsa:7364"/>
<dbReference type="UCSC" id="uc003heg.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7364"/>
<dbReference type="DisGeNET" id="7364"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000171234.13"/>
<dbReference type="GeneCards" id="UGT2B7"/>
<dbReference type="HGNC" id="HGNC:12554">
<property type="gene designation" value="UGT2B7"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000171234">
<property type="expression patterns" value="Group enriched (kidney, liver)"/>
</dbReference>
<dbReference type="MIM" id="600068">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P16662"/>
<dbReference type="OpenTargets" id="ENSG00000171234"/>
<dbReference type="PharmGKB" id="PA361"/>
<dbReference type="eggNOG" id="KOG1192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158332"/>
<dbReference type="HOGENOM" id="CLU_012949_3_2_1"/>
<dbReference type="InParanoid" id="P16662"/>
<dbReference type="KO" id="K00699"/>
<dbReference type="OMA" id="QEIMSTF"/>
<dbReference type="OrthoDB" id="508327at2759"/>
<dbReference type="PhylomeDB" id="P16662"/>
<dbReference type="TreeFam" id="TF315472"/>
<dbReference type="BioCyc" id="MetaCyc:HS10272-MONOMER"/>
<dbReference type="BRENDA" id="2.4.1.17">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P16662"/>
<dbReference type="Reactome" id="R-HSA-156588">
<property type="pathway name" value="Glucuronidation"/>
</dbReference>
<dbReference type="SABIO-RK" id="P16662"/>
<dbReference type="SIGNOR" id="P16662"/>
<dbReference type="BioGRID-ORCS" id="7364">
<property type="hits" value="5 hits in 845 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="UGT2B7">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P16662"/>
<dbReference type="GeneWiki" id="UGT2B7"/>
<dbReference type="GenomeRNAi" id="7364"/>
<dbReference type="Pharos" id="P16662">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P16662"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="P16662">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000171234">
<property type="expression patterns" value="Expressed in intestine and 74 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P16662">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0015020">
<property type="term" value="F:glucuronosyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008209">
<property type="term" value="P:androgen metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0052695">
<property type="term" value="P:cellular glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006629">
<property type="term" value="P:lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR002213">
<property type="entry name" value="UDP_glucos_trans"/>
</dbReference>
<dbReference type="InterPro" id="IPR035595">
<property type="entry name" value="UDP_glycos_trans_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00201">
<property type="entry name" value="UDPGT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00375">
<property type="entry name" value="UDPGT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0328">Glycosyltransferase</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0753">Steroid metabolism</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="UDP-glucuronosyltransferase 2B7" id="PRO_0000036031">
<location>
<begin position="24"/>
<end position="529"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="493"/>
<end position="509"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="UDP-glucuronic acid" evidence="19">
<location>
<begin position="373"/>
<end position="379"/>
</location>
</feature>
<feature type="binding site" description="UDP-glucuronic acid" evidence="19">
<location>
<position position="398"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="67"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="68"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12233719." id="VAR_057327">
<original>A</original>
<variation>S</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In allele UGT2B7*1; dbSNP:rs7439366." id="VAR_012342" evidence="5 14">
<original>Y</original>
<variation>H</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35590824." id="VAR_057328">
<original>N</original>
<variation>S</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>H</original>
<variation>A</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced androsterone and tetrachlorocatechol glucuronosyltransferase activities; abolished hyodeoxycholic acid glucuronosyltransferase activity." evidence="8">
<original>D</original>
<variation>A</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished androsterone glucuronosyltransferase activity; reduced hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>D</original>
<variation>N</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>T</original>
<variation>V</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished androsterone glucuronosyltransferase activity; reduced hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>H</original>
<variation>A</variation>
<variation>E</variation>
<location>
<position position="374"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished androsterone glucuronosyltransferase activity; reduced hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>N</original>
<variation>A</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished androsterone glucuronosyltransferase activity; reduced hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>G</original>
<variation>D</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished androsterone glucuronosyltransferase activity; no change in hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>G</original>
<variation>S</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>D</original>
<variation>A</variation>
<variation>N</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities." evidence="8">
<original>Q</original>
<variation>A</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="290"/>
<end position="297"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="298"/>
<end position="302"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="304"/>
<end position="308"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="318"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="331"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="351"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="359"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="368"/>
<end position="373"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="377"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="390"/>
<end position="392"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="399"/>
<end position="407"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="408"/>
<end position="410"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="411"/>
<end position="414"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="422"/>
<end position="434"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="436"/>
<end position="445"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="448"/>
<end position="450"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2O6L"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10702251"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11186130"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15470161"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15472229"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17442341"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18177842"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18674515"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18719240"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19022937"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2159463"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23288867"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23756265"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26220143"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18719240"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000305"/>
<evidence key="20" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10702251"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15470161"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15472229"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17442341"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18177842"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18674515"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18719240"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19022937"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23288867"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23756265"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26220143"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:12554"/>
</source>
</evidence>
<sequence length="529" mass="60721" checksum="94B8B31CE929C836" modified="2018-04-25" version="2" precursor="true">MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRGHEVTVLASSASILFDPNNSSALKIEIYPTSLTKTELENFIMQQIKRWSDLPKDTFWLYFSQVQEIMSIFGDITRKFCKDVVSNKKFMKKVQESRFDVIFADAIFPCSELLAELFNIPFVYSLSFSPGYTFEKHSGGFIFPPSYVPVVMSELTDQMTFMERVKNMIYVLYFDFWFEIFDMKKWDQFYSEVLGRPTTLSETMGKADVWLIRNSWNFQFPYPLLPNVDFVGGLHCKPAKPLPKEMEDFVQSSGENGVVVFSLGSMVSNMTEERANVIASALAQIPQKVLWRFDGNKPDTLGLNTRLYKWIPQNDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFADQPDNIAHMKARGAAVRVDFNTMSSTDLLNALKRVINDPSYKENVMKLSRIQHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAAHDLTWFQYHSLDVIGFLLVCVATVIFIVTKCCLFCFWKFARKAKKGKND</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

